NEUROCRINE BIOSCIENCES INC
NBIX
54 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Jan 15 9:19 PM | KYLE W GANO | Proposed Sale | 65,000 | $139.51 | $9.1M | — | View → |
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 21 11:24 PM | William H RastetterDirector | Option Exercise | 3,318 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:23 PM | POPS RICHARD FDirector | Option Exercise | 3,318 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:22 PM | Christine A PoonDirector | Option Exercise | 3,318 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:22 PM | Leslie V NorwalkDirector | Option Exercise | 1,659 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:21 PM | MORROW GEORGE JDirector | Option Exercise | 3,318 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:21 PM | Johanna MercierDirector | Option Exercise | 3,318 | — | 0(D) | View → |
| May 21, 2026 | May 21 11:21 PM | LYONS GARY ADirector | Option Exercise | 1,659 | — | 0(D) | View → |
| May 19, 2026 | May 21 9:49 PM | Kevin Charles GormanDirector | Option Exercise | 205,088 | $43.24 | 0(D) | View → |
| May 15, 2026 | May 18 9:50 PM | POPS RICHARD FDirector | Option Exercise | 15,000 | $47.89 | 0(D) | View → |
| Feb 13, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 13, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Grant/Award | 51,830 | $124.12 | 7,735(D) | View → |
| Feb 12, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,133 | — | 6,401(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 3,352 | — | 1,812(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Grant/Award | 134,972 | $124.12 | 20,142(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,907 | — | 14,721(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Grant/Award | 64,788 | $124.12 | 9,669(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 5,407 | — | 2,717(D) | View → |